| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/31/2001 | US6268134 Method and applications for efficient genetic suppressor elements |
| 07/31/2001 | US6268119 Method for separating cells |
| 07/31/2001 | US6267960 Administering monoclonal antibody designated atcc no. hb-12612, hb-12616, atcc no. hb12618, or atcc no. hb-12617 which binds specifically to extracellular domain of prostate stem cell antigen (psca) to inhibit growth of prostate tumor |
| 07/31/2001 | US6267959 Monoclonal antibodies having property of causing apoptosis and used as anticancer agents |
| 07/31/2001 | US6267955 Mononuclear phagocytes and their use to promote axonal regeneration |
| 07/31/2001 | CA2276548C Improved methods for the preparation of endotoxin-binding proteins |
| 07/31/2001 | CA2218372C Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 07/31/2001 | CA2107553C Monoclonal antibodies to stem cell factor receptors |
| 07/31/2001 | CA2079877C Bacillus thuringiensis strains and their genes encoding insecticidal toxins |
| 07/31/2001 | CA2069428C A mammalian cytokine, il-11 |
| 07/31/2001 | CA2018511C Process for the preparation of purified albumin solutions |
| 07/28/2001 | CA2331674A1 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same |
| 07/28/2001 | CA2297448A1 Improved inhibition of graft versus host disease |
| 07/26/2001 | WO2001053825A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 07/26/2001 | WO2001053541A1 Antisense modulation of caspase 8 expression |
| 07/26/2001 | WO2001053540A1 Antisense modulation of pepck-cytosolic expression |
| 07/26/2001 | WO2001053530A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053528A1 Antisense inhibition of ptp1b expression |
| 07/26/2001 | WO2001053504A1 Replication deficient adenovirus vectors |
| 07/26/2001 | WO2001053503A1 Neural progenitor cells from hippocampal tissue and a method for isolating and purifying them |
| 07/26/2001 | WO2001053500A1 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| 07/26/2001 | WO2001053490A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | WO2001053487A2 Human sperm specific lysozyme-like proteins |
| 07/26/2001 | WO2001053486A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | WO2001053482A1 VITAMIN D3-RESPONSE SEQUENCE LOCATED IN THE 5'-UPSTREAM OF p27/KiP1 GENE AND METHOD FOR SCREENING DRUG BY USING THE SEQUENCE |
| 07/26/2001 | WO2001053469A2 Phosphatases |
| 07/26/2001 | WO2001053468A2 Lipid metabolism enzymes and polynucleotides encoding them |
| 07/26/2001 | WO2001053467A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | WO2001053465A1 Human embryoid body-derived cells |
| 07/26/2001 | WO2001053464A1 Method and system for determining parameters of a protocol for deferred use of immunocompetent cells |
| 07/26/2001 | WO2001053462A1 Liver tissue source |
| 07/26/2001 | WO2001053461A1 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 07/26/2001 | WO2001053460A1 Identification of genetic components of drug response |
| 07/26/2001 | WO2001053449A1 Cell and tissue culture device with improved culture fluid circulation |
| 07/26/2001 | WO2001053352A2 Sperm specific proteins |
| 07/26/2001 | WO2001053351A2 Apoptin bindendes protein |
| 07/26/2001 | WO2001053348A2 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 07/26/2001 | WO2001053347A2 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 07/26/2001 | WO2001053346A1 Human cystine knot polypeptide |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053339A2 Egg specific surface proteins |
| 07/26/2001 | WO2001053338A2 Cbp86, a sperm specific protein |
| 07/26/2001 | WO2001053317A1 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/26/2001 | WO2001053315A1 Antisense modulation of ara70 expression |
| 07/26/2001 | WO2001052871A1 Preparation and xenotransplantation of porcine islets |
| 07/26/2001 | WO2001052870A1 Treatment of congestive heart failure by pretreated autologous blood |
| 07/26/2001 | WO2001052864A1 Antisense modulation of cot oncogene expression |
| 07/26/2001 | WO2001052863A1 Antisense modulation of mekk2 expression |
| 07/26/2001 | WO2001052862A1 Antisense modulation of glycogen synthase kinase 3 beta expression |
| 07/26/2001 | WO2001052791A2 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
| 07/26/2001 | WO2001052664A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | WO2001052649A1 Expansion of stem and progenitor cells by beta-catenin |
| 07/26/2001 | WO2001052643A1 Transgenic goat producing milk containing human granulocyte-colony stimulating factor |
| 07/26/2001 | WO2001052642A1 Method of transferring mutant mitochondrial dna into genital cells |
| 07/26/2001 | WO2001052639A1 Use of pro-apoptotic factors in treatment of atherosclerosis |
| 07/26/2001 | WO2001052614A2 Selecting and producing t cell peptide epitopes |
| 07/26/2001 | WO2001046401A8 Embryonic or stem-like cells produced by cross species nuclear transplantation |
| 07/26/2001 | WO2001034206A8 Nucleic acid-containing complex |
| 07/26/2001 | WO2001021766A9 Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| 07/26/2001 | WO2001014415A3 Egfh2 genes and gene products |
| 07/26/2001 | WO2001010902A8 Nucleoc acids and secreted polypeptides encoded thereby |
| 07/26/2001 | WO2001007584A8 Controlled electroporation and mass transfer across cell membranes |
| 07/26/2001 | WO2001004264A3 Atherosclerosis-associated genes |
| 07/26/2001 | WO2001004148A9 Donor strand complemented pilin and adhesin broad-based vaccines |
| 07/26/2001 | WO2001002583A3 Orynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
| 07/26/2001 | WO2001001748A3 Peptide compounds that bind her2 |
| 07/26/2001 | WO2001000784A3 Compound derived from an offset orf of the ice gene |
| 07/26/2001 | WO2000071741A9 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 07/26/2001 | WO2000055194A9 Tuberculosis antigens and methods of use therefor |
| 07/26/2001 | WO2000047238A9 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients |
| 07/26/2001 | WO2000045176A3 METHOD OF IDENTIFYING N-TERMINAL proBNP |
| 07/26/2001 | WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2001 | WO2000040616A9 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/26/2001 | WO2000026388A9 Novel expression cassette for expressing genes in plant seed |
| 07/26/2001 | WO2000017361A3 Interferon-epsilon |
| 07/26/2001 | US20010009905 Adipocyte Complement-Related Protein encoded polypeptides, used in therapy and diagnosis, cell proliferation, cell death, energy homestasis; treatment of cancers, obesity, diabetes, heart disease, immunity |
| 07/26/2001 | US20010009772 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 07/26/2001 | US20010009769 Polyhydroxyalkanoates for in vivo applications |
| 07/26/2001 | US20010009767 For culturing insect cells for the expression of proteins using a baculovirus expression system, characterized in that the medium does not contain glutamine |
| 07/26/2001 | US20010009766 Dna encoding galanin galr3 receptors and uses thereof |
| 07/26/2001 | US20010009757 A closed, sterile continuous flow process by selectively binding a specific cell population to a particle having a selective binding site to form a conjugate; separating by continuous flow centrifuging; sedimentation; immunoaffinity |
| 07/26/2001 | CA2407012A1 Cell and tissue culture device with enhanced culture fluid flow |
| 07/26/2001 | CA2398842A1 Replication deficient adenovirus vectors |
| 07/26/2001 | CA2398710A1 Egg specific surface proteins |
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398239A1 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 07/26/2001 | CA2398083A1 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 07/26/2001 | CA2397946A1 Lipid metabolism enzymes |
| 07/26/2001 | CA2397931A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 07/26/2001 | CA2397927A1 Liver tissue source |
| 07/26/2001 | CA2397901A1 Cbp86, a sperm specific protein |
| 07/26/2001 | CA2397896A1 Human sperm specific lysozyme-like proteins |
| 07/26/2001 | CA2397838A1 Sperm specific proteins |
| 07/26/2001 | CA2397617A1 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 07/26/2001 | CA2397571A1 Apoptin-associating protein |
| 07/26/2001 | CA2397324A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | CA2397205A1 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/26/2001 | CA2397059A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes |
| 07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |